In the final episode of Kicking the Nicotine Habit, It's a Brain Thing. The MedEvidence! doctors roll out the clinical trials on Cytisinicline, an approved therapy in Central and Eastern West Europe for the past 20 years.
Dr. Michael Koren, MedEvidence! Podcast Host, Lead Investigator on 2,000+ clinical trials, and practicing Cardiovascular physician with co-host Michelle McCormick talks with Dr. Mitchell Rothstein a clinical Pulmonary and Sleep Medicine physician for 30 years in the Jacksonville Florida area. Dr. Rothstein transitioned into Clinical Research as the Medical Director of the Phase 1 unit at Jacksonville Center for Clinical Research six years ago.
Inside this episode:
- Cytisinicline
- Alpha4beta2 Nicotine Receptor
- Clinical Trials to help quit smoking
Links to more information:
A naturally-derived alternative treatment to quit smoking
Ongoing Research of Cytisinicline for Addiction
More about Clinical Trial Participation
- Am I eligible to participate in this study?
- Why Should I participate in this study?
- What happens if I volunteer to participate in this study?
Participate in Clinical Research
Rate, Review, and Subscribe to the MedEvidence podcast to be notified when new episodes are released.
Follow MedEvidence! on Social Media to discover the Truth Behind the Data.
Facebook
Instagram
Twitter
LinkedIn
Powered by ENCORE Research Group at www.ENCOREDOCS.com
Original Air Date: April 13, 2022
